The Eli Lilly logo is seen at the company’s office on November 21, 2025 in San Diego, California, United States. Mike Black | Reuters Eli Lilly It said Thursday that its next-generation obesity drug retatrotide has cleared its first late-stage trials in type 2 diabetes patients, helping them manage blood sugar levels and lose weight. … Read more
Speaking of being stuck in a rut…with guts. You’ve tried everything to lose weight—you eat healthy, exercise more, manage stress better and get enough sleep—but nothing seems to move the needle on the scale. Are you paying attention to your chemical exposure? Obesogens are endocrine disrupting chemicals (EDCs) that sabotage weight loss efforts by altering … Read more
Novo Nordisk India’s patent on semaglutide expires this week Ride the wave of cheap generics from local drugmakers Concerns have been raised about abusive, unequal supervision HYDERABAD, March 19 (Reuters) – India’s diabetes and weight loss drug market is poised for a shake-up as Danish drugmaker Novo Nordisk ( NOVOb.CO )opens a new tab Semaglutide’s … Read more
brand newYou can now listen to Fox News articles! With millions of people using injectable GLP-1 drugs like Ozempic, Wegovy or Zepbound, many may wonder what happens if they stop. Previous clinical trials have suggested an encouraging “recovery” effect, where patients regain a significant portion of their lost weight immediately after treatment ends. However, a … Read more
Visit the News Center Even short interventions are associated with changes in the risk of heart attack, stroke, and death Sarah Moser and Alaska Adams/Washio Medicine WashU drug researchers have found that stopping GLP-1 drugs like semaglutide and terzepatide — even temporarily — increases the risk of heart attack, stroke and death compared to staying … Read more
Weight-loss medications have been associated with an increased risk of preterm birth among women who took them before pregnancy or during early pregnancy to treat preexisting diabetes. However, a large study of more than 750,000 pregnancies found that weight loss medication use was not associated with preterm birth or other birth complications. study authors, in … Read more
Analysts note that this Phase II readout puts aliglipron in line to challenge other oral GLP-1RAs on the market if it has shown Phase III success. Credit: New Africa / Shutterstock.com. Structure Therapy’s oral weight-loss drug, alaniglipron, has led to strong weight loss in a Phase II obesity trial — results that analysts suggest put … Read more
Overall obesity among US high school students has increased from 13.7% in 2013 to 15.9% in 2023 and 16.3% in 2021. Three main methods of RT: Youth obesity rates are on the rise in the United States: A Florida Atlantic University study published in the Ochsner Journal found that obesity among US high school students … Read more
1 in 5 US teenagers – 22.2% of high school students – are now classified as obese, a trend that carries serious physical and mental health risks throughout adolescence. Photo of the study: 1 in 5 US teenagers – 22.2% of high school students – are now classified as obese, a trend that carries serious … Read more
5 minutes of reading Tony Alvarado, 45, is a mathematics professor at Rice University from Houston, Texas, and has a history of heart problems. A combination of too little exercise, stress eating, and drinking contributed to weight gain that threatened his livelihood. Here’s how he put his act together through a comprehensive diet plan that … Read more